Chris Stein

Chris Stein has extensive experience in leadership roles within the pharmaceutical and healthcare industries. Currently serving as President & COO of Ferndale Pharma Group, Inc. since February 2019 and simultaneously holding the same position at Ferndale Laboratories since June 1997, Chris Stein also contributed as Executive Vice President of Corporate Development. Additional roles include Vice President of Corporate Development at Eloquest Healthcare, Inc. and Biopelle, Inc., both since 2008 and 2003, respectively. Chris Stein’s involvement in governance is highlighted by serving as Vice Chair on the Board of Directors for MichBio from March 2011 to January 2018. Education includes a Bachelor of Science degree in Medical Technology from Eastern Michigan University.